More help for financial toxicity and better access to trials are just two of the recommendations from the rare cancers senate hearings.
More help for financial toxicity and better access to trials are just two of the recommendations from the rare cancers senate hearings.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.